… that release cytokines (notably IL-1, IL-6 and TNF) and … (cytokine storm) and tissue damage.
Some drugs have been studied as therapeutic targets (block to viral entry or to cytokine storm…

… life-threatening “cytokine storms” in the host … cytokine storms which may prove useful in
the clinic in the future and compare them to more traditional therapeutic candidates that target …

… Cytokine storm syndrome (CSS) has generally been described as a collection of clinical
manifestations resulting from an overactivated immune system. Cytokine storms … therapeutic …

… Immunoregulatory therapies target the cytokine storms induced by severe acute respiratory
syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes COVID‑19, and include …

… Here, we present a literature review regarding current and potential pharmacologic
treatments that specifically aim to target the cytokine storm in the battle against COVID-19. …

… and progression while also revealing potential therapeutic targets [76]. One effective CRS …
player in severe sepsis-associated cytokine storms and a potential therapeutic target [90,91]. …

… levels of pro-inflammatory cytokines are produced during the crosstalk between epithelial
cells and immune cells in COVID-19, which has linked the cytokine storm (CS) with the severe …

… Therapeutic efficacy of these Nrf2 inducers is unknown for the cytokine storm and ARDS.
Potentially, Nrf2 inducers can be used to prevent cytokine storm or during its manifestation in …

… been suggested that a cytokine storm of hyper-inflammation is … therapies which target the
COVID-19 induced cytokine storm. … Virus-induced cytokine storm is associated with Secondary …

… It has been determined that cytokine storm is a major cause of … cytokine storm has become
a key therapeutic target. Although specific mechanisms of the occurrences of cytokine storms …